menu
Showcases Stock ranks

ADMA Biologics Inc. (ADMA) (ADMA)
0 (0%)
Open: Pre. Close:
High: Low:
Volume: Market Cap: 0M
ADMA Biologics Inc is a biopharmaceutical company. The Company develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases.
Share on Facebook   Tweet this page
Price Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 3.224 - 3.241 3.241 - 3.255
Low: 2.823 - 2.841 2.841 - 2.856
Close: 3.039 - 3.071 3.071 - 3.098
Stock Technical Analysis
Overall:     
Target: Six months: 4.32
One year: 5.05
Support: Support1: 2.31
Support2: 1.45
Resistance: Resistance1: 3.70
Resistance2: 4.32
Pivot: 2.45
Moving Averages: MA(5): 3.02
MA(20): 2.61
MA(100): 3.81
MA(250): 4.12
MACD: MACD(12,26): -0.12
Signal(12,26,9): -0.28
%K %D: %K(14,3): 78.59
%D(3): 73.98
RSI: RSI(14): 53.82
52-Week: High:
Low:
Change(%): -24.6
Average Vol(K): 3-Month: 240364
10-Days: 474790
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.

ADMA has closed below upper band by 18.0%. Bollinger Bands are 74.5% wider than normal. The large width of the bands suggest high volatility as compared to ADMA's normal range. The bands have been in this wide range for 14 bars. This is a sign that the current trend might continue.
Stock chart
Stock News
2020-03-19
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ: BMRA )( announced commencement of international shipment of rapid COVID-19 test) BioNTech SE – ADR (NASDAQ: BNTX ) Imara Inc (NASDAQ: IMRA ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 18) 89bio Inc (NASDAQ: ETNB ) AC Immune SA (NASDAQ: ACIU ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adial Pharmaceuticals Inc (NASDAQ: ADIL ) ADMA Biologics Inc (NASDAQ: ADMA ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Agenus Inc (NASDAQ: AGEN ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Aikido Pharma Inc (NASDAQ: AIKI ) Akorn, Inc. (NASDAQ: AKRX ) Alkermes Plc (NASDAQ: ALKS ) Allogene Therapeutics Inc (NASDAQ: ALLO ) Alterity Therapeutics Ltd (NASDAQ: ATHE ) AMAG Pharmaceuticals, Inc.

2020-03-13
The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo Corporation (NASDAQ: MASI ) Down In The Dumps (Biotech stocks that hit 52-week lows March 12.) Abbott Laboratories (NYSE: ABT ) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Aileron Therapeutics Inc (NASDAQ: ALRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Akari Therapeutics PLC (NASDAQ: AKTX ) Akcea Therapeutics Inc (NASDAQ: AKCA ) Akero Therapeutics Inc (NASDAQ: AKRO ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc.

Financial Analysis
Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 86.35
Shares Float (M) 64.09
% Held by Insiders 7.35
% Held by Institutions 43.86
Shares Short (K) 5360
Shares Short Prior Month (K) 4650
Stock Financials
EPS -0.888
Book Value (p.s.) 0.440
PEG Ratio
Profit Margin -164.50
Operating Margin -141.14
Return on Assets (ttm) -24.0
Return on Equity (ttm) -210.1
Qtrly Rev. Growth 196.7
Gross Profit (p.s.) -0.118
Sales Per Share 0.340
EBITDA (p.s.) -0.442
Qtrly Earnings Growth
Operating Cash Flow (M) -76.19
Levered Free Cash Flow (M) -61.32
Stock Valuation
P/E -3.46
P/E Growth Ratio -0.01
P/BV 6.98
P/S
P/CF -3.48
Dividend Yield
Dividends & Splits
Dividend
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator